CompletedPhase 1NCT02747030

Phase I RVC With Ocriplasmin for CRVO

Studying Central retinal vein occlusion

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Universitaire Ziekenhuizen KU Leuven
Principal Investigator
Peter Stalmans, MD PhD
UZ Leuven
Intervention
Ocriplasmin intravenously(drug)
Enrollment
4 enrolled
Eligibility
18-100 years · All sexes
Timeline
20162017

Study locations (1)

Collaborators

KU Leuven

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02747030 on ClinicalTrials.gov

Other trials for Central retinal vein occlusion

Additional recruiting or active studies for the same condition.

See all trials for Central retinal vein occlusion

← Back to all trials